Aim: The effectiveness of nutritional supplementation on drug-seeking behavior of amphetamine-addicted rats during withdrawal was investigated using a biased conditioned place preference (CPP) paradigm. Method: Twenty-four male Sprague-Dawley rats exhibiting baseline preference for the black chamber during a 20-minute pre-conditioning exploration of the CPP box completed the study. On alternate days of an 8-day schedule, twelve rats (Group AMP) were randomly selected, given either amphetamine sulfate (5 mg/ml, i.p.) and confined to the white chamber; or vehicle (1 ml saline, i.p.) and confined to the black chamber. A significant increased percentage time spent and number of entries made by Group AMP to the drug-paired, white chamber on the test day confirmed amphetamine addiction. Group AMP subsequently received increasing doses of amphetamine over 6 days. Following acute drug withdrawal, their CPP performance was compared with that of vehicle treated rats (Group SAL). Groups AMP and SAL were equally divided and randomly assigned to animals fed chow reconstituted with the nutritional supplement (AMP-S and SAL-S) over 8 weeks or standard rat chow (AMP-N and SAL-N). CPP performances for all rats were determined blindly from video recordings following this period. Results: Nutritionally supplemented, amphetamine withdrawn rats (AMP-S) exhibited significantly decreased percentage entries and time spent in the white chamber (p < 0.05), indicating preference for the black chamber and diminished drug-seeking behavior. ANOVA revealed that after 8 weeks of dietary supplementation, AMP-S rats behaved like drug-naïve, control animals. Conclusion: Drug-seeking behavior by amphetamine-addic-How to cite this paper:
Introduction
Substance dependence and substance abuse, previously considered to be separate entities, have recently been incorporated into the disorder classified in the DSM-5 as Drug Addiction [1] [2] . Drug addiction, which is a recognized brain disease, is a chronically relapsing disorder, characterized by compulsion to seek and take the drug, loss of control in limiting intake, and emergence of a negative emotional state that includes dysphoria, anxiety, and irritability when access to the drug is prevented. There are currently three recognized stages of drug addiction, namely: 1) the basal ganglia-driven binge/intoxication stage; 2) an extended amygdala-driven withdrawal/negative affect stage; and 3) a prefrontal cortex-driven preoccupation/anticipation stage. Each stage is associated with disturbances in a specific series of neural subsystems, and involves complex neurotransmitter interactions [1] .
The ability of a drug of abuse to induce reward or intoxication is initially, although not solely, related to its ability to increase levels of dopamine (DA), particularly in the nucleus accumbens of the basal forebrain. This site-specific increase in DA then enables the individual to predict reward, imprint incentive value to reinforcers and rapidly learn reward associations [3] . This means that the power to create an addiction does not merely lie in induction of timely hedonic pleasure, but in the evolution of complex neuroadaptations, involving DA and other neurotransmitters and receptors such as glutamate, GABA, endocannabinoids, and opioids. They synergistically produce the behaviors associated with addiction [1] . Research on addiction trajectories has shown that the continued use of an abused substance gradually impairs neuronal function, eventually impacting the very capacity of the drug dependent person or addict to exert free will [2] Amphetamine is a powerful stimulant of the central nervous system (CNS) with high addictive potential. It is also highly anorexigenic. The amphetamine-induced peptides, known as cocaine and amphetamine-regulated transcript (CART) 1 and 2, have been identified as being specifically produced upon administration of amphetamine to rodents. They decrease food intake and increase energy expenditure [3] . CART is widely expressed in the CNS, including brain regions controlling food intake, and direct administration of CART decreases food intake [4] . CART is believed to increase metabolism by causing an increase in the release of thyrotropin-releasing hormone (TRH) that in turn A. Webber-Waugh et al. Journal of Behavioral and Brain Science stimulates release of thyroid stimulating hormone to cause an increase in heat production by muscle and adipose tissue [5] .
Amphetamine abusers therefore experience reduced food intake, increased caloric expenditure, and suffer from a malnutrition related to starvation. Starvation itself induces protein and fat catabolism that leads to loss of organ volume and function. Food restriction causing weight loss below approximately 15 to 20 percent of ideal body weight increases the potential for development of gastroparesis [6] , with the associated nausea, early satiety and anorexia which may add to the nutritional insult of amphetamine abuse [7] . Furthermore, persons with gastroparesis are at high risk of developing small bowel bacterial overgrowth and the consequent increased gut transit, maldigestion and malabsorption; painting a picture of an addict caught in a cycle of inadequate nutrition [6] .
The gastrointestinal, neuronal and caloric perturbations resulting from amphetamine abuse are indicators that nutrition therapy is vital for individuals with substance use disorders. Furthermore, disordered and dysfunctional eating patterns pervade attempts at abstinence, potentially worsening the withdrawal experience of the addict. Centers and caregivers are more likely to have improved results if nutrition and abstinence are addressed simultaneously. Thus, specific macro-and micro-nutrient supplementation is recommended early in the treatment cycle to supplement calories, neurotransmitter regulation and restoration of gut health [8] .
This study therefore investigated the effectiveness of a proprietary formulation of a nutritional supplement on drug-seeking behavior in drug-withdrawn rodents using an amphetamine addicted rat model, as confirmed by the conditioned place preference (CPP) paradigm, an accepted gold standard for rodent addiction studies.
Materials and Methods
A biased CPP paradigm was used to create an amphetamine rat addiction model to test the drug-seeking behavioral response to nutritional supplementation during drug withdrawal. A three (3) chambered CPP apparatus, measuring 75 cm × 30 cm × 25 cm, was employed. The single black, white and grey chambers could each be isolated from the other by a sliding door on either side of the central grey chamber. The box had a Perspex lid to facilitate viewing and video recording. The floor of the white chamber was covered with shiny transparent Perspex; while the floor of the black chamber was covered with wire mesh and saw-dust, creating two contrasting chambers with distinct visual and tactile cues, representing a biased paradigm. Figure 1 shows a diagram of the CPP box used in this study. The apparatus was thoroughly cleaned with a dilute solution of disinfectant upon completion of exploration by each rat.
Subjects
Twenty four (24) three (3) month old male Sprague-Dawley rats weighing approximately 250 -350 g, were obtained following institutional ethical approval of 
The Conditioned Place Preference Paradigm
Phase 1: Pre-conditioning, Selection and Group Assignments Animals selected for inclusion in the experiment were allowed an initial twenty (20) minute exploration of the CPP apparatus, and scores of chamber entries and time spent in each chamber were recorded manually and correlated with the video recorded data. An entry was recorded when all four paws of the rat were placed in a chamber. Animals displaying at least 80% preference for the black CPP chamber during pre-conditioning, assessed as greater number of entries and time spent in the black chamber, were selected and randomly assigned to one of two treatment groups, AMP or SAL, each containing twelve (12) rats [9] [10].
Phase 2: Conditioning
During the conditioning phase, rats assigned to the amphetamine treatment group (Group AMP) received intra-peritoneal injections (i.p.) of 5 mg/kg/ml of amphetamine sulfate (Sigma, USA) dissolved in physiological saline (0.9%). This dose has been shown to produce place preference in a number of studies [9] [10]. Rats in Group SAL were given only vehicle (1 ml 0.9% saline, i.p.).
Conditioning consisted of 8 days of daily, group-assigned i.p. injections, followed immediately by individual confinement to the white, "non-preferred" or black "preferred" chamber of the CPP box for thirty (30) minutes. On days 1, 3, 5 and 7, Group AMP received amphetamine sulfate (Sigma, USA) while nondrug exposed, vehicle treated rats received saline (Group SAL). Each rat in Groups AMP and SAL was then confined individually to the white "non-pre- ceived an injection of saline (1 ml, i.p.) and were confined individually for 30 minutes in the black "preferred" chamber. Thus, Group AMP rats were conditioned to pair amphetamine with the white chamber and saline with the black chamber [9] [10]. On Day 9, rats were placed individually in the grey chamber, sliding doors then removed, and allowed to explore the CPP box. The number of entries and time spent in the white chamber were recorded over 20 minutes and the percentage entries and time spent calculated from the total. Data obtained revealed that all animals assigned to Group AMP exhibited a significant and positive CPP drug-seeking behavior for the white chamber ( Figure 2 ).
Phase 3: Amphetamine Addiction and Drug Withdrawal
The addiction phase then ensued, with daily doses of amphetamine sulfate (5, 5, 6, 6, 7, 7 mg/kg/ml, i.p.) that increased in concentration over a 6-day period.
Group SAL rats received only vehicle (i.p.) over the same period and represented the non-drug exposed controls for the addiction phase of the study.
Rats were subsequently taken through a period of three days without drug, vehicle or CPP exposure, and were fed standard rat chow with water ad libitum.
On day 4, following drug withdrawal, each animal was individually placed in the grey start chamber and allowed a 20-minute period of exploration of the CPP box after the sliding doors were removed ( Figure 2 ). The number of entries made into, and the time spent in each chamber, were recorded manually for all rats and the data compared with scores obtained from video recordings of exploration of the CPP box.
Phase 4: Oral Nutritional Supplementation
The orally administered, nutritional supplementation regimen used in this study consisted of three separate pharmaceutical grade components: 1) a mega vitamin with higher levels of calcium and magnesium; 2) omega 3 and 6 fish oils;
and 3) a supplement capsule consisting of basic amino acids with higher levels of tyrosine (Manufacturer: All The Whey, Inc. Paoli PA, USA).
Nutritionally supplemented animals were proportionally fed a combination of the named component, at 0.123 g/day, 0.123 g/day and 0.0408 g/day, respectively, over a period of 8 weeks. These doses were calculated based on a 350 g rat, after proportions previously used in other studies for administration to a 75 kg man were scaled down [11] .
Preparation of the nutritional supplement for oral treatment involved crushing and weighing the megavitamins; whereas, the fish oil tablets were opened and drained into a calibrated beaker and the relevant volumes removed. Supplement capsules were also opened and the powder weighed for correct dosing.
All animals were individually caged for the duration of the supplementation period.
The initial Groups AMP and SAL were further equally divided, assigned a numerical code and randomly assigned to either the supplemented diet or standard rat chow group, as indicated below: Journal of Behavioral and Brain Science 
Data Analysis
Data on the mean percentage time (from a total time of 20 minutes) and entries (from the total entries into all arms of the CPP box) into the white CPP chamber by each animal were analyzed using the SPSS-19 software. Mean scores for white chamber percent entries and time were analyzed within groups using the t-test for pre-conditioning, the withdrawal period and after the 8 weeks of supplemented versus standard diet. Comparisons of the mean percentage time and entries into the white CPP chamber were also measured between groups, and analyzed using one-way ANOVA. Post-hoc analysis was performed using the Tukey test due to the distribution of the group means.
Results

Pre-Conditioning
A robust pre-conditioning milieu was created before drug treatment was initiated. Rats in all 4 treatment groups had significantly higher baseline percent entries into and time spent in the black chamber (p < 0.05) prior to test conditions.
1) Within-group comparison of mean percent entries into the white CPP chamber for Groups AMP-S and AMP-N for all phases of the experiment Amphetamine-treated rats in both AMP-S and AMP-N groups showed significantly increased percent entries into the drug-paired, white chamber of the CPP box during drug withdrawal, compared to their performance during pre-conditioning (p < 0.001). This is demonstrated in Figure 3 .
After 8 weeks of consuming the nutritional supplement, there was a significant decrease in percent entries into the drug-paired, white chamber (p < 0.05) by AMP-S rats, compared to SAL-S and SAL-N. There was also no significant difference between their initial pre-conditioning percent entries and those observed for the AMP-S rats after 8 weeks of nutritional supplementation.
On the other hand, non-supplemented, AMP-N rats continued to have significantly increased percent entries into the white chamber after 8 weeks of consuming standard rat chow (p < 0.05).
2) Within-group comparison of mean percent time in the white CPP chamber for groups AMP-S and AMP-N for all phases of the experiment All amphetamine-treated rats (AMP-S and AMP-N) showed significantly increased percent time in the drug-paired, white chamber of the CPP box during drug withdrawal, compared to their pre-conditioned time (p < 0.001). This is demonstrated in Figure 4 .
After 8 weeks of consuming the nutritional supplement, there was a significant decrease in percent time in the drug-paired chamber (p < 0.05) by AMP-S rats. Also, there was no significant difference between the initial pre-conditioning white chamber percent time, and that noted after 8 weeks of supplementation. Journal of Behavioral and Brain Science 3) Comparison of mean percent entries into the white, drug-paired chamber for all treatment groups after drug treatment and after 8 weeks: between-group comparisons After drug dosing and during the drug withdrawal period, amphetamine treated rats (Groups AMP-S and AMP-N) showed significantly higher percent entries into the drug-paired white chamber, compared to the saline treated groups, SAL-S and SAL-N (F (3,18) = 8.824; p < 0.001). This is shown in Figure 5 .
However, after 8 weeks of nutritional supplementation, previously amphetamine addicted rats in Group AMP-S made significantly decreased percent entries into the previously drug-paired white chamber, compared to both saline treated groups, SAL-S and SAL-N (F (3, 18) = 32.639; p < 0.001).
In contrast, following 8 weeks of standard, non-supplemented chow, amphetamine-addicted rats in Group AMP-N continued to show significantly increased percent entries into the previously drug paired white chamber (F (3, 18) During drug withdrawal, amphetamine treated rats (Groups AMP-S and AMP-N) spent a significantly increased percent time in the drug-paired white chamber, compared to the saline treated groups (SAL-S and SAL-N; F (3,18) = 7.025; p < 0.001). This is shown in Figure 6 .
After 8 weeks of nutritional supplementation, previously amphetamine addicted rats in Group AMP-S spent significantly decreased percent time in the previously drug-paired white chamber, compared to both supplemented and non-supplemented, saline treated groups (SAL-S and SAL-N; F (3,18) = 10.251; p = 0.006).
After 8 weeks of standard, non-supplemented chow, amphetamine-addicted rats in Group AMP-N continued to have a significantly higher percent time in the drug paired white chamber (F (3,18) = 10.251; p = 0.006) compared to saline treated groups, i.e. SAL-S and SAL-N.
Discussion
Summary of Main Findings
The results of this study show for the first time, that complete reversal of amphetamine drug-seeking behavior in stimulant addicted animals can be demonstrated solely after application of a nutritional intervention. 
Role of Nutrition in Addiction Recovery
These results complement those of an extensive, 50-year review of the literature related to nutrition as therapy in drug abuse recovery done previously [12] . They corroborate evidence that vitamin, mineral and amino acid therapy can reduce withdrawal symptoms, increase treatment retention and quality of life and contribute to higher abstinence rates in stimulant addicted subjects [12] . The rehabilitative role of amino acid supplementation with tyrosine and tryptophan, aimed at restoration of catecholamine balance in creating a foundation for complete recovery, has also been previously discussed [13] .
A cutting-edge review of the neurobiology of addiction recognizes three stages of the disease, and affirms that each stage influences and is fed by disordered circuitry in different brain regions. In the binge/intoxication stage, previously neutral stimuli become associated with drug availability, promoting habit formation that fosters excessive drug seeking via increases in dopamine and glutamate neurotransmission. Those authors associate this first stage with diminished reward function via dopamine and opioid peptide deficits (2) . The animals in this study were likely confined to that initial stage of the continuum of drug addiction, as we employed a relatively short time line. The human chronic drug addict, however, would also likely have derangements in executive function via the dysregulation of glutamatergic, GABAergic, and dopaminergic neuronal Bearing in mind the gut and neuronal derangements associated with stimulant addiction, it is likely that the balance of fatty acids, minerals and vitamins in this supplement may potentially replenish catecholamine neurotransmitters [14] . It may also contribute to the restoration of gut health and neuronal cellular function in order to improve CNS regulatory mechanisms and restore normal decisions to behave as if there had been no drug exposure.
A nutritional supplement that contained fish oil (5.6 grams a day); a multiple vitamin; a brain supplement with ginkgo and vinpocetine; acetylcholine (acetyll-carnitine and huperzine A), and antioxidant (alpha-lipoic acid and n-acetylcysteine) was found to play a significant role in substance abuse rehabilitation and brain injury reversal [15] . These authors reported on improvements in cognitive functions of attention, memory, reasoning and speed of information processing. Brain SPECT scans provided information on brain perfusion showing improvements in cerebral blood flow also. Our results complement those
findings, but we have demonstrated more effectively the ability of our supplement to significantly decrease drug seeking behaviour.
Strengths and Limitations
Our work demonstrated unequivocally that rats became amphetamine addicts, as we employed the international gold standard for addiction studies. Our method of including the nutritional supplement in the first feed of each day enabled the results to be more uniform, regardless of how much each animal consumed. The limitations are that we can only interpret cue-directed animal behavior in terms of positive CPP or drug-seeking behavior; and negative CPP or drug aversion. The physiological derangements and other qualitative and emotional aspects of human addiction may not have been modeled in our study.
This study opens the door to continued behavioral analysis of nutrient therapy for drug addiction. Much scope exists for inclusion of this supplement in stimulant drug abuse rehabilitation programs.
